NASDAQ: AXNX | Healthcare / Medical Devices & Instruments / USA |
58.67 | -1.16 | -1.94% | Vol 363.11K | 1Y Perf 70.52% |
Apr 19th, 2021 16:00 DELAYED |
BID | 56.51 | ASK | 61.01 | ||
Open | 59.68 | Previous Close | 59.83 | ||
Pre-Market | - | After-Market | - | ||
- - | - -% |
Target Price | 65.89 | Analyst Rating | Strong Buy 1.13 | |
Potential % | 12.31 | Finscreener Ranking | ★★★★ 55.29 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★★ 52.54 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★ 53.88 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Market Cap | 2.44B | Earnings Rating | Strong Sell | |
Price Range Ratio 52W % | 92.01 | Earnings Date | 6th May 2021 |
Today's Price Range 57.8759.81 | 52W Range 30.0061.16 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | 0.29% | ||
1 Month | 2.68% | ||
3 Months | 15.49% | ||
6 Months | 24.96% | ||
1 Year | 70.52% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -41.84 | |||
ROE last 12 Months | -22.57 | |||
ROA (5Y Avg) | -14.79 | |||
ROA last 12 Months | -18.89 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -29.73 | |||
Return on invested Capital Q | -3.39 | |||
Return on invested Capital Y | -20.52 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 6.10 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-40.20 | ||||
8.66 | ||||
28.63 | ||||
- | ||||
-39.70 | ||||
-2.26 | ||||
8.66 | ||||
6.91 | ||||
2.28B | ||||
Forward PE | -153.41 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.70 | ||||
7.20 | ||||
0.03 | ||||
0.11 | ||||
-28.30 | ||||
Leverage Ratio | 1.20 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
60.20 | ||||
-74.20 | ||||
-72.40 | ||||
- | ||||
-46.99 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
85.24M | ||||
2.05 | ||||
925.77 | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2020 | -0.32 | -0.29 | 9.38 |
Q03 2020 | -0.52 | -0.24 | 53.85 |
Q02 2020 | -0.59 | -0.54 | 8.47 |
Q01 2020 | -0.56 | -0.43 | 23.21 |
Q04 2019 | -0.64 | -0.75 | -17.19 |
Q03 2019 | -0.73 | -0.89 | -21.92 |
Q02 2019 | -0.51 | -0.68 | -33.33 |
Q01 2019 | -0.40 | -0.47 | -17.50 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2021 QR | -0.41 | -20.59 | Negative |
6/2021 QR | -0.35 | -6.06 | Negative |
12/2021 FY | -1.19 | 2.46 | Positive |
12/2022 FY | -0.39 | 15.22 | Positive |
Next Report Date | 6th May 2021 |
Estimated EPS Next Report | -0.41 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 363.11K |
Shares Outstanding | 41.52M |
Trades Count | 4.76K |
Dollar Volume | 47.84M |
Avg. Volume | 553.32K |
Avg. Weekly Volume | 361.36K |
Avg. Monthly Volume | 443.43K |
Avg. Quarterly Volume | 569.08K |
Axonics Modulation Technologies Inc. (NASDAQ: AXNX) stock closed at 58.67 per share at the end of the most recent trading day (a -1.94% change compared to the prior day closing price) with a volume of 363.15K shares and market capitalization of 2.44B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 302 people. Axonics Modulation Technologies Inc. CEO is Raymond Wayne Cohen.
The one-year performance of Axonics Modulation Technologies Inc. stock is 70.52%, while year-to-date (YTD) performance is 17.53%. AXNX stock has a five-year performance of %. Its 52-week range is between 30 and 61.16, which gives AXNX stock a 52-week price range ratio of 92.01%
Axonics Modulation Technologies Inc. currently has a PE ratio of -40.20, a price-to-book (PB) ratio of 8.66, a price-to-sale (PS) ratio of 28.63, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -18.89%, a ROC of -29.73% and a ROE of -22.57%. The company’s profit margin is -46.99%, its EBITDA margin is -72.40%, and its revenue ttm is $85.24 Million , which makes it $2.05 revenue per share.
Of the last four earnings reports from Axonics Modulation Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.41 for the next earnings report. Axonics Modulation Technologies Inc.’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for Axonics Modulation Technologies Inc. is Strong Buy (1.13), with a target price of $65.89, which is +12.31% compared to the current price. The earnings rating for Axonics Modulation Technologies Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Axonics Modulation Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Axonics Modulation Technologies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 8.87, ATR14 : 2.82, CCI20 : 17.42, Chaikin Money Flow : 0.17, MACD : 1.74, Money Flow Index : 54.93, ROC : -2.04, RSI : 52.05, STOCH (14,3) : 62.95, STOCH RSI : 0.00, UO : 65.10, Williams %R : -37.05), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Axonics Modulation Technologies Inc. in the last 12-months were: Alfred J. Ford (Option Excercise at a value of $49 700), Alfred J. Ford (Sold 41 967 shares of value $1 747 389 ), Danny L. Dearen (Option Excercise at a value of $217 927), Danny L. Dearen (Sold 182 508 shares of value $6 955 513 ), John Woock (Option Excercise at a value of $20 800), John Woock (Sold 33 810 shares of value $1 662 275 ), Juliet Tammenoms Bakker (Sold 13 953 shares of value $597 963 ), Raymond Wayne Cohen (Option Excercise at a value of $0), Raymond Wayne Cohen (Sold 166 469 shares of value $6 907 656 ), Rinda Sama (Option Excercise at a value of $456 585), Rinda Sama (Sold 154 162 shares of value $6 738 123 ), Robert E. Mcnamara (Sold 9 167 shares of value $475 133 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Axonics Modulation Technologies Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence.
CEO: Raymond Wayne Cohen
Telephone: +1 949 396-6322
Address: 26 Technology Drive, Irvine 92618, CA, US
Number of employees: 302
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.